Abstract: A hand truck for carrying and lifting a load comprising spaced vertical columns each having a channel. Rollers are captured in each of said channels that are capable of vertical movement along its respective channel. A first toe plate is affixed to said columns and adapted to extend horizontally during use. A second toe plate is attached to the rollers and adapted to move vertically along said columns between upper and lower positions. The first and second toe plates are in nesting relationship when the second toe plate is in its lower position.

Abstract: An electro-mechanical drug delivery device comprises a main body having a distal end and a proximal end. The distal end is configured to attach to a dispense interface. A separable housing that can prevent an administration of a drug by the drug delivery device, the housing configured to cover at least a portion of the distal end of the main body when the separable housing is coupled to the main body of the drug delivery device. A conduction element is provided by the main body and configured for establishing an electrical connection with an electrical connector. Establishment of the electrical connection is prevented when the housing does not cover at least a portion of the distal end of the main body. The electrical connection may be established when the housing covers at least a portion of the distal end of the main body of the drug delivery device.

Abstract: A computerized electro-mechanical drug delivery device configured to deliver at least one dose of two or more medicaments. The device comprises a control unit. An electro-mechanical drive unit is operably coupled to the control unit and a primary reservoir for a first medicament and a secondary reservoir for a fluid agent, e.g. a second medicament. An operator interface is in communication with the control unit. A single dispense assembly is configured for fluid communication with the primary and the secondary reservoir. Activation of the operator panel sets a first dose from the primary reservoir and based on the first dose and a therapeutic dose profile, the control unit is configured to determine a dose or range of the fluid agent. Alternatively, the control unit determines or calculates a dose or range of a third medicament. Further, a dispense interface for use with a drug delivery device is disclosed.

Abstract: A toy figure has a loosely held skeleton with multiple structural elements resembling or simulating bones of the skeleton. The skeleton also includes a fluid or liquid material that resembles a soft tissue coupled to a portion of the structural elements. In addition, a play set includes a receptacle in which a viscous fluid is located so that a portion of the skeleton can be moved to engage the fluid. A child can move a portion of the skeleton away from the receptacle, thereby displaying the fluid on the structural elements.

Abstract: A toy figure is disclosed herein, the toy figure having: an upper body portion; a lower body portion, the upper portion being rotatably secured to the lower portion; at least one appendage movably secured to the lower portion; and a drive mechanism coupling the at least one appendage to the upper portion, wherein movement of the at least one appendage causes rotation of the upper portion with respect to the lower portion.

Abstract: A drug delivery system for the controlled release of a pharmaceutically-active compound by oral route comprises an intercalate of a layered double hydroxide having, before intercalation, layers of metal hydroxides, and having intercalated therein a pharmaceutically-active compound having at least one anionic group. A preferred layered double hydroxide is one that has layers which comprise [LiAl2(OH)6]+. The drug delivery system has use in the delivery of drugs such as 4-biphenylacetic acid, Diclofenac, Gemfibrozil, Ibuprofen, Naproxen, 2-Propylpentanoic acid and Tolfenamic acid.

Abstract: The present invention relates to per-substituted pentalene compounds, including permethylpentalene and precursors thereof. In particular, the invention provides substituted pentalene compounds and methods of preparing substituted pentalene compounds; complexes of metals with substituted pentalene compounds and methods for their production; and the use of complexes of metals with substituted pentalene compounds in catalysis.

Abstract: A drug delivery system for the controlled release of a pharmaceutically-active compound by oral route comprises an intercalate of a layered double hydroxide having, before intercalation, layers of metal hydroxides, and having intercalated therein a pharmaceutically-active compound having at least one anionic group. A preferred layered double hydroxide is one that has layers which comprise [LiAl2(OH)6]+. The drug delivery system has use in the delivery of drugs such as 4-biphenylacetic acid, Diclofenac, Gemfibrozil, Ibuprofen, Naproxen, 2-Propylpentanoic acid and Tolfenamic acid.

Abstract: A process for producing alumina from bauxite is described in which bauxite is treated with an alkali to form a mixture comprising a solution of aluminum-containing ions and alumina trihydrate is precipitated from the solution. The process comprises treatment of the solution before or after the precipitation step with a layered double hydroxide in order to remove impurities from the solution by intercalation into the layers in the double hydroxide. The double hydroxide may contain layers of the formula: [LiAl2(OH)6]+.

Abstract: A method for creating a multi-level business alliance in non-exclusive geographical areas. The multi-level alliance includes a founding firm, and at least one foundation firm. The alliance also may include firms at other levels. Alliance members share resources, clients and revenue based on a predefined formula. This enables multiple firms to work together and provide a broader range of services to each other's clients while remaining independent of each other. Moreover, it enables smaller alliance members to have access to the resources of larger members and vice versa.

Abstract: A drug delivery system for the controlled release of a pharmaceutically-active compound by oral route comprises an intercalate of a layered double hydroxide having, before intercalation, layers of metal hydroxides, and having intercalated therein a pharmaceutically-active compound having at least one anionic group. A preferred layered double hydroxide is one that has layers which comprise [LiAl2(OH)6]+. The drug delivery system has use in the delivery of drugs such as 4-biphenylacetic acid, Diclofenac, Gemfibrozil, Ibuprofen, Naproxen, 2-Propylpentanoic acid and Tolfenamic acid.

Abstract: A nucleoside phosphate may be separated from a solution containing it using the ability of the nucleoside phosphate to intercalate into a layered double hydroxide. In particular, a first nucleoside phosphate may be separated from a second nucleoside phosphate by treating a solution containing the first and second nucleoside phosphates with a layered double hydroxide to preferentially intercalate the first nucleoside phosphate into the layered double hydroxide. The layered double hydroxide containing the intercalated nucleoside phosphate may be subsequently treated to recover the nucleoside phosphate. The methods disclosed provide useful procedures whereby nucleoside phosphates of enhanced purity may be obtained.